Last Price$70.5(2.1%)
Market Cap$13.4B
17.8%
Industry median - 3.6%
5Y Historical average - 11.1%
198.6%
Industry median - 8.2%
5Y Historical average - 679.6%
152.8%
Industry median - (12.5%)
5Y Historical average - 156.5%
820.5%
Industry median - 10.8%
5Y Historical average - 160.7%
BMRN Growth Rating
BMRN Growth rating
7.1
BMRN Growth rating performance
BMRN Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with BMRN Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$13.4B | 7.1 | 10.8% | 17.8% | 10.0% | N/A | 152.8% | 48.9% | N/A | 820.5% | |
$124.8B | 6.9 | 21.5% | 11.5% | 8.6% | N/A | N/A | (962.4%) | N/A | N/A | |
$77.0B | 5.6 | 12.6% | 8.3% | 2.4% | 16.1% | 10.3% | 3.1% | 12.5% | (5.7%) | |
$34.4B | 6.3 | 106.9% | 127.3% | 76.3% | (9.7%) | (57.5%) | (132.2%) | N/A | (70.8%) | |
$30.7B | 5.4 | 59.2% | 23.0% | 28.6% | (23.2%) | (38.5%) | (26.5%) | (36.7%) | N/A | |
$24.0B | 6.2 | 90.9% | (28.0%) | (28.0%) | 36.5% | N/A | (182.9%) | (3.1%) | N/A | |
$14.5B | 4.0 | 4.5% | (3.8%) | 35.4% | (19.0%) | (9.0%) | 144.6% | 10.7% | (7.3%) | |
$14.2B | 4.0 | 14.5% | 14.8% | 10.1% | (35.1%) | (91.0%) | 3,417.0% | (18.0%) | (47.6%) | |
$13.8B | 7.5 | 14.7% | 23.6% | 9.1% | N/A | 25.6% | 6.8% | N/A | 44.5% | |
$13.3B | 6.1 | (100.0%) | N/A | N/A | (0.9%) | (92.8%) | 11.4% | 44.6% | 84.8% | |
$1,846.9M | 5.9 | 50.5% | 50.5% | 50.7% | 25.3% | 20.9% | (35.6%) | 3.3% | (43.8%) |
FAQ
What is the BioMarin Pharmaceutical Inc. (BMRN) revenue growth?
The BioMarin Pharmaceutical Inc. (BMRN) revenue growth is 17.8%, which is lower than the industry median of 3.6% and the 5-year historical average of 11.1%.
What is the BioMarin Pharmaceutical Inc. (BMRN) operating income growth?
The BioMarin Pharmaceutical Inc. (BMRN) operating income growth is 198.6%, compared to the industry median of 8.2% and the 5-year historical average of 679.6%.
What is the BioMarin Pharmaceutical Inc. (BMRN) EPS (Earnings Per Share) growth?
The BioMarin Pharmaceutical Inc. (BMRN) EPS growth is 152.8%, compared to the industry median of (12.5%) and the 5-year historical average of 156.5%.
What is the BioMarin Pharmaceutical Inc. (BMRN) Free Cash Flow (FCF) growth?
The BioMarin Pharmaceutical Inc. (BMRN) Free Cash Flow growth is 820.5%, compared to the industry median of 10.8% and the 5-year historical average of 160.7%.